IFNG and myeloid sarcoma: In this study, we further examined the expression of IFN-γ and IBA1 in postmortem tissues from control persons and patients with ALS and MS and found that both markers in brains from MS and ALS patients were dramatically increased compared to those from control persons (Fig. S12A–C).